Protean BioDiagnostics, an Orlando based innovative diagnostics company is focusing its innovative test development efforts on helping patients with breast cancer using innovative new approaches for cancer diagnostics.
Read More
Breast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read More
A liquid biopsy is essentially a simple blood test. But that’s not all. With today’s advanced technology we can now examine the blood of cancer patients with unprecedented accuracy and sensitivity to detect important features of the disease that can be extremely helpful to better plan treatment.
Read MoreProtean BioDiagnostics has opened new liquid Biopsy trial in partnership with Epic Sciences for women with recurrent breast cancer in the USA and Canada.
Read MoreDiaceutics announces the establishment of a dedicated Advisory Panel of experts to support and inform the development and rollout of its revolutionary DXRX platform – the world’s first diagnostic network for precision medicine.
Read MoreDiaceutics announces the establishment of a dedicated Advisory Panel of experts to support and inform the development and rollout of its revolutionary DXRX platform – the world’s first diagnostic network for precision medicine.
Read More